These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 37492528)
1. Köppen K; Fatykhova D; Holland G; Rauch J; Tappe D; Graff M; Rydzewski K; Hocke AC; Hippenstiel S; Heuner K Front Cell Infect Microbiol; 2023; 13():1224356. PubMed ID: 37492528 [TBL] [Abstract][Full Text] [Related]
2. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032 [TBL] [Abstract][Full Text] [Related]
3. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171 [TBL] [Abstract][Full Text] [Related]
4. Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida. Sarva ST; Waldo RH; Belland RJ; Klose KE PLoS One; 2016; 11(8):e0158631. PubMed ID: 27537327 [TBL] [Abstract][Full Text] [Related]
5. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R; Harris G; Conlan JW; Chen W Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863 [TBL] [Abstract][Full Text] [Related]
6. A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia. Jayakar HR; Parvathareddy J; Fitzpatrick EA; Bina XR; Bina JE; Re F; Emery FD; Miller MA BMC Microbiol; 2011 Aug; 11():179. PubMed ID: 21819572 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604 [TBL] [Abstract][Full Text] [Related]
8. A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain. Matz LM; Petrosino JF Microbiologyopen; 2021 Feb; 10(2):e1170. PubMed ID: 33970545 [TBL] [Abstract][Full Text] [Related]
9. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy. Schmitt DM; O'Dee DM; Horzempa J; Carlson PE; Russo BC; Bales JM; Brown MJ; Nau GJ PLoS One; 2012; 7(2):e31172. PubMed ID: 22355343 [TBL] [Abstract][Full Text] [Related]
10. Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis. Mortensen BL; Fuller JR; Taft-Benz S; Kijek TM; Miller CN; Huang MT; Kawula TH Infect Immun; 2010 Dec; 78(12):5022-32. PubMed ID: 20921148 [TBL] [Abstract][Full Text] [Related]
11. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy. Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W PLoS One; 2010 Oct; 5(10):e13349. PubMed ID: 20967278 [TBL] [Abstract][Full Text] [Related]
12. A human macrophage-hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica. Rennert K; Otto P; Funke H; Huber O; Tomaso H; Mosig AS BMC Microbiol; 2016 Jan; 16():2. PubMed ID: 26739172 [TBL] [Abstract][Full Text] [Related]
13. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages. Bradford MK; Elkins KL Sci Rep; 2020 Jul; 10(1):12023. PubMed ID: 32694562 [TBL] [Abstract][Full Text] [Related]
14. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403 [TBL] [Abstract][Full Text] [Related]
15. Differential Substrate Usage and Metabolic Fluxes in Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859 [No Abstract] [Full Text] [Related]
16. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Green M; Choules G; Rogers D; Titball RW Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452 [TBL] [Abstract][Full Text] [Related]